Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Modulation of Micrornas by Aspirin in Cardiovascular Disease Publisher Pubmed



Paseban M1 ; Marjaneh RM2 ; Banach M3, 4 ; Riahi MM5 ; Bo S6 ; Sahebkar A7, 8, 9
Authors

Source: Trends in Cardiovascular Medicine Published:2020


Abstract

Aspirin is among the most widely prescribed drugs in cardiovascular and cerebrovascular diseases for both primary and secondary prevention. The major mechanisms underlying its benefits are the inhibitory effects on platelet activation and prostanoid biosynthesis induced by COX-1 and COX-2 inactivation. MicroRNAs (miRNAs) are newly proposed mediators of the effects of aspirin. In this review, we summarize the evidence on the links between miRNAs and aspirin use in relation to cardiovascular diseases. In addition, we discuss the studies suggesting a possible role for miRNAs as biomarkers of aspirin resistance, a condition during which atherothrombotic events occur despite aspirin use, and which affects a considerable proportion of patients with cardiovascular disease. © 2019 Elsevier Inc.
Related Docs
View other Related Docs
1. Micrornas: Key Players in Virus-Associated Hepatocellular Carcinoma, Journal of Cellular Physiology (2019)
2. Endometrial Pinopode Biomarkers: Molecules and Micrornas, Journal of Cellular Physiology (2018)
3. Molecular Aspects of Pancreatic Β-Cell Dysfunction: Oxidative Stress, Microrna, and Long Noncoding Rna, Journal of Cellular Physiology (2019)
Experts (# of related papers)
View all Related Experts
Bahman Rashidi (5)
Ebrahim Esfandiari (2)
Other Related Docs
4. Microrna in Leukemia: Tumor Suppressors and Oncogenes With Prognostic Potential, Journal of Cellular Physiology (2019)
5. Micro-Rnas As Critical Regulators of Matrix Metalloproteinases in Cancer, Journal of Cellular Biochemistry (2018)
6. Cervical Cancer Diagnosis: Insights Into Biochemical Biomarkers and Imaging Techniques, Combinatorial Chemistry and High Throughput Screening (2021)
7. Molecular Imaging and Oral Cancer Diagnosis and Therapy, Journal of Cellular Biochemistry (2017)
8. Tumor-Associated Macrophages and Epithelial–Mesenchymal Transition in Cancer: Nanotechnology Comes Into View, Journal of Cellular Physiology (2018)
9. Molecular Aspects of Diabetes Mellitus: Resistin, Microrna, and Exosome, Journal of Cellular Biochemistry (2018)
10. State of the Art in Microrna As Diagnostic and Therapeutic Biomarkers in Chronic Lymphocytic Leukemia, Journal of Cellular Physiology (2018)
11. Exosomes and Micrornas: New Potential Therapeutic Candidates in Alzheimer Disease Therapy, Journal of Cellular Physiology (2019)
12. Mesenchymal Stem Cells: A New Platform for Targeting Suicide Genes in Cancer, Journal of Cellular Physiology (2018)
13. Anti-Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis, Journal of Cellular Physiology (2017)
14. Plasminogen Activator Inhibitor Type-1 As a Regulator of Fibrosis, Journal of Cellular Biochemistry (2018)
15. The Story of Nanoparticles in Differentiation of Stem Cells Into Neural Cells, Neurochemical Research (2019)
16. Diet and Cancer Prevention: Dietary Compounds, Dietary Micrornas, and Dietary Exosomes, Journal of Cellular Biochemistry (2018)
17. Gastric Cancer Diagnosis: From Imaging Techniques to Biochemical Biomarkers, Current Molecular Medicine (2021)
18. Chemopreventive and Therapeutic Potential of Curcumin in Esophageal Cancer: Current and Future Status, International Journal of Cancer (2019)
19. Association of Serum Microrna-21 Levels With Visfatin, Inflammation, and Acute Coronary Syndromes, Heart and Vessels (2017)
20. Green Tea and Its Anti-Angiogenesis Effects, Biomedicine and Pharmacotherapy (2017)